Globus Medical (GMED) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.086x

Based on the latest financial reports, Globus Medical (GMED) has a cash flow conversion efficiency ratio of 0.086x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($412.11 Million) by net assets ($4.77 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Globus Medical market capitalisation for the company's overall valuation and market capitalisation.

Globus Medical - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Globus Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Globus Medical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Globus Medical ranked by their cash flow conversion efficiency. Explore GMED operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
LandMark Optoelectronics
TWO:3081
0.057x
Apogee Therapeutics, Inc. Common Stock
NASDAQ:APGE
-0.060x
Lineage, Inc. Common Stock
NASDAQ:LINE
0.025x
Wynn Resorts Limited
NASDAQ:WYNN
-0.543x
Sprott Physical Gold and Silver Trust
TO:CEF
-0.001x
Jiangsu Yanghe Brewery Joint-Stock Co Ltd
SHE:002304
0.010x
Piraeus Financial Holdings S.A
AT:TPEIR
0.109x
Oil India Limited
NSE:OIL
0.054x

Annual Cash Flow Conversion Efficiency for Globus Medical (2010–2025)

The table below shows the annual cash flow conversion efficiency of Globus Medical from 2010 to 2025. View GMED stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $4.57 Billion $753.45 Million 0.165x +32.19%
2024-12-31 $4.18 Billion $520.64 Million 0.125x +104.63%
2023-12-31 $4.00 Billion $243.50 Million 0.061x -36.99%
2022-12-31 $1.85 Billion $178.47 Million 0.097x -39.07%
2021-12-31 $1.74 Billion $276.27 Million 0.159x +20.21%
2020-12-31 $1.51 Billion $198.79 Million 0.132x +7.63%
2019-12-31 $1.40 Billion $171.97 Million 0.123x -19.97%
2018-12-31 $1.19 Billion $181.64 Million 0.153x -7.05%
2017-12-31 $967.78 Million $159.53 Million 0.165x -20.20%
2016-12-31 $832.08 Million $171.89 Million 0.207x +21.17%
2015-12-31 $715.32 Million $121.96 Million 0.170x +26.07%
2014-12-31 $585.45 Million $79.17 Million 0.135x -31.66%
2013-12-31 $472.36 Million $93.47 Million 0.198x -0.05%
2012-12-31 $386.50 Million $76.52 Million 0.198x -26.81%
2011-12-31 $282.48 Million $76.41 Million 0.271x -13.41%
2010-12-31 $228.19 Million $71.29 Million 0.312x --

About Globus Medical

NYSE:GMED USA Medical Devices
Market Cap
$8.39 Billion
Market Cap Rank
#2562 Global
#930 in USA
Share Price
$74.08
Change (1 day)
-0.11%
52-Week Range
$55.10 - $96.82
All Time High
$96.82
About

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting… Read more